SCHEMBL10089949

SCHEMBL10089949

Cc1cccnc1-n1nc(Cn2nnc(C(F)(F)F)n2)cc1C(=O)Nc1c(C)cc(Cl)cc1C(=O)NC1CCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.38
MAPK14 Q16539 2/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
GRM5 P41594 1/20 0.34
PDE4B Q07343 2/20 0.34
CNR1 P21554 4/20 0.33
CNR2 P34972 4/20 0.33
CRHR2 Q13324 1/20 0.33
MCHR1 Q99705 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
P2RX7 Q99572 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13085060 0.95 CRHR1 (0.36) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL10090039 0.93 CRHR1 (0.35) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL685487 0.93 CRHR1 (0.38) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL13085228 0.92 MAPK14 (0.44) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL13085363 0.91 CRHR1 (0.36) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL10090014 0.90 MAPK14 (0.34) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL13085232 0.90 PDE4B (0.34) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL13085091 0.90 CRHR1 (0.36) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL10089928 0.90 SSTR4 (0.35) CRHR1MAPK14MAPK13MAPK12MAPK11
SCHEMBL10089957 0.90 CRHR1 (0.35) CRHR1MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 CRHR1 3984/4885MAPK14 2788/4885MAPK13 3630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.